{"name":"Frances R Levin","slug":"frances-r-levin","ticker":"","exchange":"","domain":"","description":"Frances R Levin is a pharmaceutical company focused on the development of treatments for addiction disorders. The company has two key drug candidates in its pipeline, both of which are currently discontinued.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE1Nc01tODZzR0VEU1NPUmxkZlpYLUtwR21RTnpfTzJXbjdWWkJrdFlBM0ZUUVRBTGIzQUFHdkdlcFZxVnppakpPN010Zl9KUmt0Z1lqVWdDZzIxOFRZaWNZNnJpd3o1R0FXeW42OEFFWQ?oc=5","date":"2024-10-09","type":"pipeline","source":"Psychiatry Online","summary":"The Neurocircuitry of Substance Use Disorder, Treatment, and Change: A Resource for Clinical Psychiatrists - Psychiatry Online","headline":"The Neurocircuitry of Substance Use Disorder, Treatment, and Change: A Resource for Clinical Psychiatrists","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9ZelhWZFlITG5FcGp3MzJUU0ZJZHRCTUF0dVFGanZuaUJFdDNWTHkxUHk2UURlam5HdEZkTTc5QlVJQXlUNTl5eDNDYm9OYUFJcGlMOEdqXzh3YnBjZnBJVk5FUldyNEFDbi11alRR?oc=5","date":"2024-02-13","type":"trial","source":"Psychiatry Online","summary":"An Approach to Enhancing Medication Treatment for Opioid Use Disorder in the HEALing Communities Study - Psychiatry Online","headline":"An Approach to Enhancing Medication Treatment for Opioid Use Disorder in the HEALing Communities Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNR0dWRGgtdnhYTklrTU4xeFRkRHdXSzl2c01zNEhWZ0JsWEdNR1ZZeXNscjBTWE15ZU1SR3lIWTdMZWg1RDhCWTM3U1MzdWc3TlYyT21wRUdSRmlLaDc2WUZQbGtkWHNwc0NGRUxjT1ZWX3EwQlNLNEJnRlJ1MkdPWmhEclR6NU1ZVG5yanpkU0ZvZ0FiZ3YzaGJVUHRtVTVKdXR6alVSWGp3WEttVFVZalFtTWE?oc=5","date":"2023-07-28","type":"trial","source":"SciTechDaily","summary":"First-in-Class Drug To Treat Cannabis Use Disorder Shows Great Promise in Clinical Trial - SciTechDaily","headline":"First-in-Class Drug To Treat Cannabis Use Disorder Shows Great Promise in Clinical Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQWTRGY2VkRkFDYTNjdW1LYWV1cXI3X1I1X0dueUJ2Rko2eHNzRzFtWE56U2diM2xTLU1pTk5HbEN3YUdLOFU1dHdGczFXMndZcU9VVTFnT3U0dXU1SnUzb01PRUNxUWllOTJJaEhvd1paRVlaNGkyZFo2TC0tY3pCOHRHOUdTa1dPTDVydlJpcUdDMWZWY2FQQi16eWczOEx6aWJ1Mzd4S2k?oc=5","date":"2023-06-07","type":"trial","source":"Columbia University Department of Psychiatry","summary":"Drug to Treat Cannabis Use Disorder Shows Promise in Clinical Trial - Columbia University Department of Psychiatry","headline":"Drug to Treat Cannabis Use Disorder Shows Promise in Clinical Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE9nVGx2VUp1NHVnVXNXWkNIQzRiaDZ6RkltalQ5dEhESWlKTGdFYjdUQTBIMzJwblRpQWpudzhCRjFOVXZkdkpSTHVSb3VPNWdGV1JkVmQtWDBCek1Vc1ZtS3NRVlN2ekctZ2VXTUJodVU?oc=5","date":"2019-06-24","type":"trial","source":"Psychiatry Online","summary":"A Single Ketamine Infusion Combined With Mindfulness-Based Behavioral Modification to Treat Cocaine Dependence: A Randomized Clinical Trial - Psychiatry Online","headline":"A Single Ketamine Infusion Combined With Mindfulness-Based Behavioral Modification to Treat Cocaine Dependence: A Random","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE1wNFk2R1k1ZWhKeGlRbm1HbFdMaDhNcVFvRVFNZ3NYR3FSSmIxUGVBamQxX05HSWI5VndNb1JoMHZib1gyY1JOd3BOWnNzUHhJSWFONmZfRktVQ3ExeXFQRmg4TnZlQlNkT0RhUW53ejNVQUdKemc?oc=5","date":"2018-10-19","type":"trial","source":"Psychiatry Online","summary":"A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral Therapy, for the Treatment of Opioid Use Disorder - Psychiatry Online","headline":"A Randomized Trial Comparing Extended-Release Injectable Suspension and Oral Naltrexone, Both Combined With Behavioral T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTFBONlZDT0xqSjZOT3FJS1F1RU9xN0xwMlZmMXZfWFBTaW5aRTc2ck9BNFZhOUhGaWZTSVN5amY0WG85QlFMSFBwX2x5Q2w1ZUhqcmU4LQ?oc=5","date":"2017-09-06","type":"pipeline","source":"Nature","summary":"The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal - Nature","headline":"The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTE9TMkhwaVc0LVRmUjRxVlNManZQYmFHQkJLcTkxS2ZuWHlSd0lGRnN0Ql9DZlF1UHNjVlBrWGRWTUpDMW01LUN0QXZtRFhhcGdPUTdsczgxbWxqekZvRXc4LWNZMGtJYTkwUU5UMTBmMHA?oc=5","date":"2017-01-10","type":"trial","source":"Psychiatry Online","summary":"Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine - Psychiatry Online","headline":"Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Vers","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}